AureoGen Announces Licensing Agreement with Merck By: Benzinga via Benzinga February 24, 2016 at 10:05 AM EST AureoGen Biosciences Inc. today announced a licensing agreement with Merck, (NYSE: MRK), for the use of AureoGen's proprietary ... Read More >> Related Stocks: Merck & Co